A carregar...
Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma
IMPORTANCE: Targeted therapies for advanced renal cell carcinoma (RCC) have shown increased tolerability and survival advantages over older treatments in clinical trials, but understanding of real-world survival improvements is still emerging. OBJECTIVE: To compare overall and RCC-specific survival...
Na minha lista:
| Publicado no: | JAMA Netw Open |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Medical Association
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6575152/ https://ncbi.nlm.nih.gov/pubmed/31199450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2019.5806 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|